Список литературы к главе 5

1. Souttar H.S. Radium and cancer. London : W. Heinemann, 1934.

2. Cleminson F.J., Monkhouse J.P. Carcinoma of the oesophagus treated by radiation // J. Laryngol. Otol. 1934. Vol. 49, N 5. P. 313–318.

3. New G.B., Kirch W., Erich J.B. Tumots of the nose and throat // Arch. Otolaryngol. Head Neck Surg. 1939. Vol. 30, N 2. P. 283–297.

4. Иванов С.М. Химиолучевая терапия рака пищевода // Практическая онкология. 2008. Т. 9, № 1. С.21–26.

5. Shridhar R., Almhanna K., Meredith K.L. et. al. Radiation therapy and esophageal cancer // Cancer Control. 2013. Vol. 20, N 2. P. 92–110.

6. Канаев С.В., Щербаков А.М., Тюряева Е.И., Аванесян А.А. Консервативное лечение местнораспространенного и неоперабельного рака пищевода: Возможности и перспективы // Вопросы онкологии. 2012. Т. 58, № 2. С. 199–202.

7. Muijs C.T., Beukema J.C., Mul V.E. et al. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma // Radiother. Oncol. 2012. Vol. 102, N 2. P. 303–308.

8. Киселева Е.С., Зимина Е.С. Рак пищевода. Лучевая терапия злокачественных опухолей / Под ред. Е.С. Киселевой. Москва : Медицина. 1996. С. 193–208.

9. Gagliardi G., Constine L.S., Moiseenko V. et al. Radiation dose-volume effects in the heart // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76. P. 777–785.

10. Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyama et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society // Esophagus. 2015. Vol. 12. P. 1–30.

11. Mukai M., Kubota S., Morita S., Akanuma A. A pilot study of combination therapy of radiation and local administration of OK-432 for esophageal cancer: five-year survival and local control rate // Cancer. 1995. Vol. 75. P. 2276–2280.

12. Деньгина Н.В. Современные терапевтические возможности при раке пищевода // Практическая онкология. 2012. Т. 13, № 4. С. 276–288.

13. Minsky B.D., Pajak T., Ginsberg R. et al. INT0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer high-dose versus standard dose radiation therapy // J. Clin. Oncol. 2002. Vol. 20. P. 1167–1174.

14. Тюряева Е.А., Канаев С.В. Химиолучевое лечение рака пищевода: результаты и ближайшие перспективы (обзор) // Вопросы онкологии. 2012. Т. 58, № 3. С. 312–319.

15. Coia L.R. Chemoradiation as primary management of esophageal cancer // Semin. Oncol. 1994. Vol. 21, N 4. P. 483–492.

16. Nemoto K., Matsumoto Y., Yamakawa M. et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience // Int. J. Radiat. Oncol. Biol. Phys. 2000. Vol. 46, N 4. P. 921–925.

17. Sun X., Yu J., Fan X. et al. Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest // Zhonghua Zhong Liu Za Zhi. 2006. Vol. 28, N 10. P. 784–787.

18. Tanisada K., Teshima T., Ikeda H. et al. Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study // Radiat. Med. 1998. Vol. 16, N 6. P. 461–468.

19. Itoh Y., Fuwa N., Matsumoto A. et al. Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis // Radiat. Med. 2001. Vol. 19, N 5. P. 231–235.

20. Ложков А.А. Сочетанная лучевая терапия рака грудного отдела пищевода с применением брахитерапии высокой мощности: дис. ... канд. мед. наук. Москва, 2020. 134 с.

21. Perez A., Halperin E.C. Principles and practice of radiation oncology. Philadelphia : Wolters Kluwer, 2019. 7402 p.

22. Walterbos N.R., Fiocco M., Neelis K.J. et al. Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer // Clin. Transl. Radiat. Oncol. 2019. Vol. 24, № 17. P. 24–31.

23. Earlam R., Cunha-Melo J.R. Oesophogeal squamous cell carcinoma, II: a critical view of radiotherapy // Br. J. Surg. 1980. Vol. 67, N 7. P. 457–461.

24. Okawa T., Dokiya T., Nishio M. et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group // Int. J. Radiat. Oncol. Biol. Phys. 1999. Vol. 45, № 3. P. 623–628.

25. Давыдов М.И., Стилиди И.С. Рак пищевода. Москва : Издательская группа РОНЦ, Практическая медицина, 2007. 392 с.

26. Martin S., Chen J.Z., Rashid Dar A. et al. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophagealcarcinoma // Radiother. Oncol. 2011. Vol. 101, N 3. P. 431–437.

27. Kole T.P., Aghayere O., Kwah J. et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83, N 5. P. 1580–1586.

28. Nicolini G., Ghosh-Laskar S., Shrivastava S.K. et al. Volumetric modulationarc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 84, N 2. P. 553–560.

29. Welsh J., Gomez D., Palmer M.B. et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81, N 5. P. 1336–1342.

30. Борисов В.А., Шинкарев С.А., Ильин Н.В., Флоровская Н.А. Лучевая терапия рака пищевода на основе применения электромагнитной гипертермии // Медицинская радиология и радиационная безопасность. 2010. Т. 55. № 5. С. 31–34.

31. Канаев С.В., Щербаков А.М., Шулепов А.В. Сочетанная лучевая терапия неоперабельного рака пищевода // Вопросы онкологии. 2006. Т. 52, № 1. С. 32–37.

32. Канаев С.В., Туркевич В.Г., Баранов С.Б. Использование брахитерапии в лечении злокачественных опухолей // Вопросы онкологии. 2005. Т. 51, № 2. С. 245–252.

33. Palmer A., Mzenda B. Does the choice of isotope, ⁶⁰Co or ¹⁹²Ir, affect treatment planning techniques and outcomes for high dose rate (HDR) brachytherapy? // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 78, № 3. P. 853–855.

34. Арсеньев А.И., Барчук А.С., Канаев С.В. и др. Роль эндобронхиальных методов в комбинированном паллиативном лечении рака легкого // Вопросы онкологии. 2006. Т. 52, № 6. С. 701–707.

35. International Commission on Radiation Units and Measurements (ICRU) (1998) Report 58: Dose and volume specification for reporting interstitial therapy. Bethesda : Maryland, 1998. P. 23.

36. Тюряева Е.И. Роль брахитерапии в лечении рака пищевода // Вопросы онкологии. 2017. Т. 63, № 4. С. 660–665.

37. Шулепов А.В., Туркевич В.Г., Горзов П.П. Современная внутрипросветная брахитерапия рака пищевода / Диагностика и лечение опухолей. Cанкт-Петербург : СПбГМУ, 1997. С. 61–68.

38. Sur R.K., Levin C.V., Donde B. et al. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma — an International Atomic Energy Agency study // Int. J. Radiat. Oncol. Biol. Phys. 2002. Vol. 53, N 1. P. 127–133.

39. The GEC ESTRO hand-book of brachytherapy/ Edit by A. Gerbaulet, R. Pötter, J.J. Mazeron et al. Belgium : ACCO, Leuven, 2002. 679 p.

40. Канаев С.В, Тюряева Е. В., Левченко Е.В. и др. Значение внутрипросветной брахитерапии в лечении рака пищевода // Вопросы онкологии. 2015. Т. 61, № 1. С. 34–39.

41. Lettmaier S., Strnad V. Intraluminal brachytherapy in oesophageal cancer: defining its role and introducing the technique // J. Contemp. Brachytherapy. 2014. № 6. P. 236–241.

42. Welsch J., Günther P., Nieder C. et al. Survival and symptom relief after palliative radiotherapy for esophageal cancer // J. Cancer. 2016. Vol. 7, № 2. P. 125–130.

43. Bergquist H., Wenger U., Johnsson E. et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial // Dis. Esophagus. 2005. Vol. 18, № 3. P. 131–139.

44. Homs M.Y., Steyerberg E.W., Eijkenboom W.M. et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial // Lancet. 2004. Vol. 364. P. 1497–1504.

45. Allum W.H., Blazeby J.M., Griffin S.M. et al. Guidelines for the management of oesophageal and gastric cancer // Gut. 2011. Vol. 60. P. 1449–1472.

46. Spaander M.W., Baron T.H., Siersema P.D. et al. Esophageal stenting forbenign and malignant disease: European Society of GastrointestinalEndoscopy (ESGE) Clinical Guideline Appendix e1 // Endoscopy. 2016. Vol. 48. P. 939–948.

47. Varagunam M., Brand C., Cromwell D. et al. National oesophago-gastric cancer audit 2017. The Royal College of Surgeons of England. 2017. https://www.nogca.org.uk.

48. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Esophageal Cancers and Esophagogastric Junction. Version 5.2020.

49. Bhatt L., Tirmazy S., Sothi S. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center // Dis. Esophagus. 2013. Vol. 26, N 1. P. 57–60.

50. Frobe A., Jones G., Jaksic B. et al. Intraluminal brachytherapy in the management of squamous carcinoma of the esophagus // Dis. Esophagus. 2009. Vol. 22, № 6. P. 513–518.

51. Nakagawa K., Koike T., Iijima K. et al. Comparison of the long-term outcomes of endoscopic resection for superficial squamous cell carcinoma and adenocarcinoma of the esophagus in Japan // Am. J. Gastroenterol. 2014. Vol. 109, № 3. P. 348–356.

52. Grazziotin R., Reisner M.L., Rosa A.A. et al. HDR brachytherapy in advanced esophageal cancer: Analysis of the palliation of dysphagia in 108 patients // J. Clin. Oncology. 2011. Vol. 29, N 15. P. 145–199.

53. Sur R.K., Donde B., Levin V.C. Fractionated high dose ratebrachytherapy in palliation of advanced esophageal cancer // Int. J. Radiat. Oncol. Biol. Phys. 1998. Vol. 40. P. 447–453.

54. Rosenblatt E., Jones G., Sur R.K. et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency // Radiother. Oncol. 2010. Vol. 97. P. 488–494.

55. Sai H., Mitsumori M., Araki N. et al. Long-term results of definitive radiotherapy for stage I esophageal cancer // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62, N 5. P. 1339–1344.

56. Ishikawa H., Nonaka T., Sakurai H. et al. Usefulness of intraluminal brachytherapy combined with external beam radiation therapy for submucosal esophageal cancer: long-term follow-up results // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76, N 2. P. 452–459.

57. Pasquier D., Mirabel X., Adenis A. et al. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma // Int. J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65, N 5. P. 1456–1461.

58. Шарабура Т.М., Важенин А.В., Ложков А.А. и др. Опыт HDR- брахитерапии на аппарате «Multisource» опухолей различных локализаций // Сибирский онкологический журнал. 2012. Т. 54, № 6. С.73–75.

59. Flores A.D. Cancer of the oesophagus: treatment strategies and results of a Canadian randomized study / 7^th Int. Brachytherapy Working Conference — Baltimore, USA, 1992. P. 101–104.